Corient Private Wealth LLC Makes New $128,000 Investment in Nu Skin Enterprises, Inc. (NYSE:NUS)

Corient Private Wealth LLC acquired a new stake in shares of Nu Skin Enterprises, Inc. (NYSE:NUS) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor acquired 18,562 shares of the company’s stock, valued at approximately $128,000.

A number of other large investors also recently modified their holdings of the company. Ballentine Partners LLC raised its holdings in Nu Skin Enterprises by 15.5% during the 4th quarter. Ballentine Partners LLC now owns 20,856 shares of the company’s stock valued at $144,000 after buying an additional 2,800 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in shares of Nu Skin Enterprises by 3.7% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 116,424 shares of the company’s stock valued at $858,000 after acquiring an additional 4,125 shares during the period. Inspire Investing LLC raised its stake in shares of Nu Skin Enterprises by 7.8% during the fourth quarter. Inspire Investing LLC now owns 65,418 shares of the company’s stock valued at $451,000 after acquiring an additional 4,728 shares during the last quarter. Catalyst Funds Management Pty Ltd boosted its holdings in shares of Nu Skin Enterprises by 15.3% during the fourth quarter. Catalyst Funds Management Pty Ltd now owns 39,100 shares of the company’s stock worth $269,000 after purchasing an additional 5,200 shares during the period. Finally, US Bancorp DE grew its stake in shares of Nu Skin Enterprises by 424.2% in the fourth quarter. US Bancorp DE now owns 7,460 shares of the company’s stock worth $51,000 after purchasing an additional 6,037 shares during the last quarter. 82.84% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities research analysts have recently commented on the stock. DA Davidson dropped their target price on shares of Nu Skin Enterprises from $11.00 to $7.00 and set a “neutral” rating for the company in a research report on Friday, December 20th. StockNews.com upgraded shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a report on Tuesday, February 25th.

Nu Skin Enterprises Trading Down 1.0 %

NYSE:NUS opened at $7.15 on Thursday. Nu Skin Enterprises, Inc. has a one year low of $5.95 and a one year high of $14.00. The business has a fifty day moving average price of $7.37 and a 200-day moving average price of $7.08. The firm has a market capitalization of $355.52 million, a price-to-earnings ratio of -2.42 and a beta of 1.06. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.82 and a quick ratio of 1.17.

Nu Skin Enterprises (NYSE:NUS) last issued its earnings results on Thursday, February 13th. The company reported $0.38 earnings per share for the quarter, topping analysts’ consensus estimates of $0.24 by $0.14. Nu Skin Enterprises had a negative net margin of 8.46% and a positive return on equity of 5.86%. The firm had revenue of $445.55 million during the quarter, compared to analyst estimates of $441.10 million. Sell-side analysts forecast that Nu Skin Enterprises, Inc. will post 1.05 EPS for the current year.

Nu Skin Enterprises Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, March 5th. Investors of record on Monday, February 24th were issued a $0.06 dividend. The ex-dividend date of this dividend was Monday, February 24th. This represents a $0.24 dividend on an annualized basis and a dividend yield of 3.36%. Nu Skin Enterprises’s payout ratio is -8.14%.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.